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Abstract
The present study investigates the potential role of the Ca2-calmodulin-dependent type I phosphodiesterase (PDE)-
cGMP-protein kinase G (PKG) pathway in spontaneous [Ca2]i oscillations in GH3 cells using fura-2 single cell
videoimaging. Vinpocetine (2.5^50 WM), a selective inhibitor of type I PDE, induced a concentration-dependent inhibition of
spontaneous [Ca2]i oscillations in these pituitary cells, and at the same time produced an increase of the intracellular cGMP
content. The cell permeable cGMP analog N2,2P-O-dibutyryl-cGMP (dB-cGMP) (1 mM) caused a progressive reduction of
the frequency and the amplitude of spontaneous [Ca2]i oscillations when added to the medium. KT5823 (400 nM), a
selective inhibitor of cGMP-dependent protein kinase (PKG), produced an increase of baseline [Ca2]i and the disappearance
of spontaneous [Ca2]i oscillations. When KT5823 was added before vinpocetine, the PKG inhibitor counteracted the [Ca2]i
lowering effect of the cGMP catabolism inhibitor. Finally, the removal of extracellular Ca2 or the blockade of L-type
voltage-sensitive calcium channels (VSCC) by nimodipine produced a decrease of cytosolic cGMP levels. Collectively, the
results of the present study suggest that spontaneous [Ca2]i oscillations in GH3 cells may be regulated by the activity of type
I PDE-cGMP-PKG pathway. ß 1999 Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Intracellular Ca2 concentrations ([Ca2]i) in pitui-
tary cells display wide £uctuations which occur spon-
taneously and in a periodic oscillatory pattern [1,2].
These [Ca2]i oscillations are involved in some rele-
vant biological functions, such as the spontaneous
release of anterior pituitary hormones [3,4], as well
as the transcription of the mRNAs encoding for
PRL and glycoproteic hormones [5,6].
The mechanisms underlying [Ca2]i oscillations in
pituitary cells are only partially understood [1,2]. It
has been proposed that two di¡erent oscillators lo-
cated at the level of plasmamembrane (PM oscilla-
tor) and of endoplasmic reticulum Ca2 stores (ER
oscillator) are involved in the genesis of [Ca2]i os-
cillations [7]. In GH3 pituitary cells [Ca2]i oscilla-
tions seem to depend on a complex interplay between
intracellular Ca2 stores which alternatively release
and recapture Ca2 ions from the cytoplasm, and
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voltage-sensitive Ca2 channels (VSCC) which open
and close spontaneously allowing the periodical en-
trance of Ca2 ions into the cytoplasm [8,9]. Since
cAMP and cGMP through the activation of cAMP
dependent- and cGMP-dependent protein kinases
(PKA and PKG) can modify the activity of channels
and pumps located both on the ‘PM’ and on the
‘ER’ oscillators [10^14], it has been suggested that
[Ca2]i oscillations may be linked to changes in the
intracellular contents of these nucleotides [15].
Steady-state levels of cAMP and cGMP seem to be
mostly regulated by phosphodiesterases (PDE) [16].
Seven di¡erent isoforms of these enzymes have been
cloned until now. One of these seven isoenzymes,
type I PDE, is activated by Ca2-calmodulin [17]
and therefore may translate changes in [Ca2]i, in
variations of intracellular cGMP and/or cAMP con-
tents as well as play a role in the genesis of sponta-
neous [Ca2]i oscillations. In order to explore the
potential involvement of type I PDE-cGMP-PKG
pathway in this process, spontaneous [Ca2]i oscilla-
tions have been continuously monitored in single
fura-2-loaded GH3 cells using a real time videoimag-
ing apparatus after type I PDE inhibition with the
vinka alkaloid vinpocetine [18], the infusion of the
cell-permeable cGMP analog dB-cGMP and of the
selective PKG inhibitor KT5823. Furthermore, the
changes in cGMP intracellular content induced by
this drug have also been evaluated.
2. Materials and methods
2.1. Cell culture
GH3 cells were obtained from Flow Laboratories
(Irvine, UK) and grown on plastic dishes in Ham’s
F10 medium (Gibco-BRL, San Giuliano Milanese,
Italy) with 15% horse serum (Flow, Irvine, UK),
2.5% fetal calf serum (Hyclone, Logan, UT, USA),
100 IU penicillin/ml and 100 Wg streptomycin/ml.
Cells were cultured in a humidi¢ed 5% CO2 atmos-
phere. Culture medium was changed every 2 days.
For micro£uorimetric studies, cells were seeded on
glass coverslips (Fisher, Spring¢eld, NJ, USA)
coated with poly-L-lysine (30 Wg/ml) (Sigma, St.
Louis, MO, USA). All the experiments were per-
formed 2^4 days after seeding. The cells were at a
culture passage between 34 and 60.
2.2. Intracellular calcium measurements
[Ca2]i was measured using a micro£uorimetric
technique, as previously reported [20]. Brie£y: the
cells grown on glass coverslips were loaded with
5 WM fura-2 AM for 1 h at room temperature in
Krebs^Ringer saline solution (5.5 mM KCl, 160
mM NaCl, 1.2 mM MgCl2, 1.5 mM CaCl2, 10 mM
glucose, and 10 mM HEPES-NaOH, pH 7.4). At the
end of fura-2 AM loading, the coverslip was
mounted in a microscope chamber (Medical System,
Greenvale, NY) on an inverted Nikon Diaphot £uo-
rescence microscope. Throughout the experiment, the
cells were kept in Krebs^Ringer saline solution. All
the drugs tested were introduced into the microscope
chamber by fast injection. A 100-W Xenon Lamp
(Osram, Germany) with a computer-operated ¢lter
wheel bearing two di¡erent interference ¢lters (340
and 380 nm) illuminated the microscopic ¢eld with
UV light alternatively at the wavelength of 340 and
380 nm, with an interval of 500 ms between lighting
at 340 and 380 nm. The interval between each pair of
lighting was chosen according to the experimental
protocol. Emitted light was passed through a 400-
nm dichroic mirror, ¢ltered at 510 nm, and collected
by a CCD camera (Photonic Science, Robertsbridge,
East Sussex, UK) connected to a light ampli¢er (Ap-
plied Imaging, Gateshead, UK). Images were digi-
tized and analyzed with a Magiscan image processor
(Applied Imaging, Gateshead, UK). The Tardis soft-
ware (Applied Imaging, Gateshead, UK) calculated
using a calibration curve the [Ca2]i corresponding
to each pair of images, from the ratio between the
intensity of the light emitted when the cells were lit at
340 and 380 nm.
2.3. Determination of intracellular cAMP and cGMP
content
The intracellular content of cGMP was determined
using a radioimmunoassay kit (Amersham, Milan,
Italy). GH3 cells grown on 100-mm plastic dishes,
were incubated with or without the appropriate
drug in Krebs^Ringer saline solution for 2 min. At
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the end of the incubation, the medium was removed
and cells were scraped in ice-cold 60% ethanol. The
cells were then transferred into a polypropylene tube
and allowed to settle for 15 min in ice. At the end of
this period, the tubes were spun for 15 min at 14 000
rpm in a microfuge. The resulting pellet was used for
protein determination while the supernatant was
transferred into a fresh tube and concentrated under
a vacuum using a speed-vac concentrator (Savant,
Spring¢eld). The dried extracts were resuspended in
a bu¡er consisting of 0.05 M sodium acetate, pH 5.8
with 0.01% sodium azide and then acetylated using a
freshly prepared triethylamine/acetic anydride mix-
ture (2:1). One hundred microliters of the acetylation
product was assayed in duplicate using a double anti-
body RIA protocol. The standard curve ranged from
2 to 128 pmol/ml. Results were normalized for pro-
tein content. Protein determination was carried out
using the method of Bradford [21].
cAMP concentrations were determined using a
commercial [3H]cAMP assay system (Amersham,
Milan, Italy). The cells, grown in 100-mm plastic
dishes, were incubated with vinpocetine or vehicle
in Krebs^Ringer solution for 2 min. The reaction
was stopped placing the dishes in ice; then the me-
dium was removed and substituted with ice-cold acid
ethanol (1 ml 1 N HCl/100 ml ethanol). Intracellular
cAMP was extracted overnight under shaking at 4‡C.
Then ethanol was neutralized with Tris-HCl, trans-
ferred into a fresh tube, and concentrated under vac-
Fig. 1. Concentration-dependency of vinpocetine-induced inhibition of [Ca2]i oscillations in GH3 cells. (A) Concentration^e¡ect curve
of vinpocetine-induced inhibition of [Ca2]i transient frequency. [Ca2]i oscillation inhibition was quanti¢ed as the ratio between pulse
frequency (peaks/min) in the presence of increasing vinpocetine concentrations and in its absence. The plot was ¢tted to the equation
y = max/[1+(x/k)n], where max was the maximal ratio value, k was 3.24 and Hill coe⁄cient (nH) was 1.24. (B) Concentration^e¡ect de-
pendency of the vinpocetine-induced suppression of [Ca2]i oscillation amplitude. [Ca2]i transient suppression was quanti¢ed as the
ratio between pulse amplitude ([Ca2]i nM) in the presence of increasing concentrations of vinpocetine and in its absence. The plot
was ¢tted to the equation y = max/[1+(x/k)n], where max was the maximal ratio value, k was 9.66 and Hill coe⁄cient (nH) was 0.75.
The point representing the e¡ect of 50 WM vinpocetine was omitted in this panel, since no peak was detected at this concentration.
(C) E¡ect of vinpocetine vehicle (0.2% of a 1:1 solution of acetone and DMSO) on [Ca2]i oscillations. The vehicle was added to the
chamber 500 s after the beginning of the experiment and left another 500 s before the wash. (D) E¡ect of 50 WM vinpocetine on
[Ca2]i oscillations in GH3 cells. Vinpocetine was added after 500 s of baseline [Ca2]i monitoring and left in the chamber for 500 s.
Each point of A and B represents the mean þ S.E. of at least 30 determinations performed in two di¡erent experimental sessions. To
calculate both the frequency and the amplitude of [Ca2]i oscillations, the entire traces were considered and the statistical analysis was
performed on the raw data. The traces shown in C and D are single cell recordings and are representative of the pattern of 50 cells
recorded in at least three di¡erent experimental sessions.
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uum using a speed-vac concentrator. The dried ex-
tracts were resuspended in Tris EDTA bu¡er. cAMP
was determined from the extent of [3H]cAMP bind-
ing to a cAMP-binding protein in the presence of the
sample. Brie£y, samples and standard tubes were in-
cubated with cAMP-binding protein in the presence
of [3H]cAMP for 2 h. To separate free and bound
cAMP, the samples were incubated with a charcoal
suspension and centrifuged at 3000 rpm. A 200-Wl
aliquot of the supernatant was counted in a scintilla-
tion counter after the addition of a liquid scintilla-
tion solution. The calibration curve of the assay
ranged from 1.0 to 16.0 pmol/tube. All the data
were normalized for protein content determined
with the Bradford method [21].
2.4. Mathematical analysis of spontaneous [Ca2+]i
oscillations
[Ca2]i oscillations, de¢ned as an increase of
[Ca2]i above the baseline followed by a rapid return
to baseline values, were analyzed using the DETECT
software, which is widely used for the detection of
hormonal pulses [22]. This program, through the
analysis of the ¢rst derivatives of the data and the
¢tting of straight line segments through local regions
of the data, allows for the identi¢cation of those
[Ca2]i variations which assume the signi¢cance of
[Ca2]i oscillations, and excludes those [Ca2]i varia-
tions due to technical noise. The frequency was cal-
culated as the number of peaks occurring per minute,
while the amplitude was determined as the di¡erence
between the maximal [Ca2]i value of the peak and
the minimal [Ca2]i value just before the occurrence
of the peak.
2.5. Statistical analysis of the data
All the numerical data are reported as mean þ
S.E.M. The statistical signi¢cance of the data was
calculated using the Student’s t-test for paired data.
The threshold for signi¢cance was set at P6 0.05.
2.6. Drugs and chemicals
All the chemicals were of analytical grade and
were purchased from Sigma (St. Louis, MO, USA).
Fura-2 AM, dB-cGMP, vinpocetine, KT5823 and
KT5720 were obtained from Calbiochem (La Jolla,
CA, USA).
3. Results
3.1. E¡ect of di¡erent concentrations of the type I
phosphodiesterase inhibitor vinpocetine on
[Ca2+]i oscillations and on intracellular content
of cGMP and cAMP
Vinpocetine, when added to the medium for 8.5
min in concentrations ranging from 2.5 to 50 WM,
inhibited in a concentration-dependent manner, both
the frequency and the peak amplitude of [Ca2]i os-
cillations in GH3 cells (Fig. 1A,B). The IC50 of vin-
pocetine-induced inhibition of both the frequency
and of the peak amplitude of [Ca2]i oscillations
was approximately 10 WM. The maximal inhibiting
e¡ect was achieved at 50 WM. The time course of
vinpocetine (50 WM) and its vehicle e¡ect on
[Ca2]i is depicted in Fig. 1C,D.
The same concentration of vinpocetine (50 WM),
which exerted the maximal inhibitory e¡ect on
[Ca2]i oscillations in GH3 cells, caused a doubling
of basal cGMP content in GH3 cells ; whereas it did
not modify cAMP levels (Fig. 2).
Fig. 2. E¡ect of 50 WM vinpocetine on intracellular content of
cAMP and cGMP in GH3 cells. cAMP and cGMP were ex-
tracted and quanti¢ed as described in Section 2. The results
represent the means with S.E. (vertical bars) of three separate
determinations. Asterisks indicate a signi¢cant di¡erence from
control values (P6 0.05).
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3.2. E¡ect of the PKG activator, dB-cGMP and of the
PKG inhibitor KT5823 on [Ca2+]i oscillations in
GH3 cells
As shown in Fig. 3A, when dB-cGMP was added
to the medium at a concentration of 1 mM, which is
widely used to activate PKG [23,24], a progressive
reduction in both the frequency and the amplitude
of spontaneous [Ca2]i oscillations was observed.
The complete suppression of spontaneous [Ca2]i os-
cillations occurred approximately after 7 min of in-
cubation with this PKG activator.
By contrast, KT5823, a selective inhibitor of PKG,
at a concentration of 400 nM, a value two times
higher than the IC50 [19], induced a progressive in-
crease in baseline [Ca2]i and a reduction of the am-
plitude of [Ca2]i oscillations.
3.3. E¡ect of the selective PKG inhibitor KT5823 and
of the selective PKA inhibitor KT5720 on
vinpocetine-induced suppression of spontaneous
[Ca2+]i oscillations
When KT5823 (400 nM) was preincubated 6 min
before vinpocetine, it prevented the [Ca2]i lowering
e¡ect of the type I PDE inhibitor. In fact, in the
presence of KT5823 [Ca2]i increased and [Ca2]i
oscillations disappeared (Fig. 4A).
By contrast, the speci¢c PKA inhibitor KT5720 at
a concentration of 200 nM, four times higher than its
IC50 [19], was unable to prevent the vinpocetine-in-
duced suppression of [Ca2]i oscillations and did not
modify by itself the amplitude and the frequency of
[Ca2]i oscillations (Fig. 4B)
3.4. E¡ect of extracellular Ca2+ removal or
nimodipine blockade of L-type VSCC on
intracellular cGMP and cAMP levels
Extracellular Ca2 removal or the incubation with
10 WM nimodipine induced a statistically signi¢cant
decrease (70^80%) of intracellular cGMP levels (Fig.
5A). By contrast, both Ca2 removal and L-type
VSCC blockade did not produce any change in
GH3 cell cAMP contents (Fig. 5B).
4. Discussion
The results obtained in the present study showed
that the vinca alkaloid derivative vinpocetine, an in-
hibitor of the Ca2/calmodulin-dependent type I
PDE [18], abolished the occurrence of [Ca2]i oscil-
Fig. 3. E¡ect of the cell permeable cGMP-analog dB-cGMP
and of the PKG inhibitor KT5823 on the occurrence of sponta-
neous [Ca2]i oscillations in GH3 cells. (A) E¡ect of 1 mM dB-
cGMP on spontaneous [Ca2]i oscillations in GH3 cells. dB-
cGMP (1 mM) was added to the chamber after 500 s of moni-
toring of [Ca2]i oscillation occurrence in basal conditions, and
left in the chamber for 1100 s. (B) E¡ect of 400 nM KT5823
on spontaneous [Ca2]i oscillations in GH3 cells. KT5823 (400
nM) was added after 500 s of monitoring of [Ca2]i transient
occurrence in basal conditions and left in the chamber for an-
other 1000 s. All traces shown in the ¢gure are single cell re-
cordings and are representative of the pattern of 30 cells re-
corded in three di¡erent experimental sessions.
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lations lowering [Ca2]i to baseline values in GH3
cells. Since the inhibition of type I PDE produced
a selective elevation of intracellular cGMP content,
the e¡ect of vinpocetine might be attributed to the
increase of this cyclic nucleotide. This hypothesis was
supported by the evidence that the cell-permeable
cGMP-analog dB-cGMP was also e¡ective in lower-
ing [Ca2]i to baseline values and in suppressing
[Ca2]i oscillations. Therefore, the data here reported
suggest that type I PDE could be involved in the
genesis of [Ca2]i oscillations through a cGMP-de-
pendent pathway. Since both cGMP and dB-cGMP
are potent activators of the PKG [23], the e¡ect of
vinpocetine on [Ca2]i oscillation occurrence could
be attributed to PKG activation. In fact, when
PKG was inhibited by its speci¢c blocker KT5823,
[Ca2]i oscillations disappeared even though it in-
duced a constant elevation of baseline [Ca2]i. This
ability is compatible with the hypothesis suggesting
the existence of an inhibitory and £uctuating func-
tion exerted by PKG on VSCC. Thus when PKG
Fig. 4. E¡ect of the selective PKG inhibitor KT5823 and of the
selective PKA inhibitor KT5720 on vinpocetine-induced sup-
pression of spontaneous [Ca2]i oscillations in GH3 cells. (A)
E¡ect of KT5823 preincubation on vinpocetine-induced [Ca2]i
transient suppression. KT5823 (400 nM) was added to the me-
dium 360 s before vinpocetine. (B) E¡ect of KT5720. KT5720
was added to the medium 350 s before vinpocetine. The traces
are representative of 30 cells recorded in at least three separate
experimental sessions.
Fig. 5. E¡ect of extracellular Ca2 removal or nimodipine
blockade of L-type VSCC on intracellular cGMP and cAMP
levels. (A) E¡ect of extracellular Ca2 removal or nimodipine
blockade on cGMP levels. Intracellular cGMP concentrations
were detected after 1 h of Ca2-free incubation and after 5 min
of nimodipine addition. (B) E¡ect of extracellular Ca2 removal
or nimodipine-induced VSCC blockade on cAMP levels. The
times of incubation were the same as reported for cGMP deter-
minations. The results represent the means with S.E. (vertical
bars) of six determinations. Asterisks indicate a signi¢cant dif-
ference from respective control values (P6 0.05).
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activity is constantly blocked by KT5823 the £uctu-
ating and inhibitory role played by the kinase cannot
be exerted, and GH3 cells do not display oscillations,
but set up baseline [Ca2]i at a higher level. In light
of this model by which PKG controls [Ca2]i oscil-
lations through the modulation of VSCC activity, the
persistence of high baseline [Ca2]i when both the
PKG inhibitor and vinpocetine were present can be
explained by the predominant e¡ect of the PKG in-
hibitor KT5823 that overcame the increased levels of
cGMP induced by vinpocetine. The speci¢city of vin-
pocetine in activating the cGMP-PKG pathway in
GH3 cells was further supported by the failure of
the PKA inhibitor KT5720 to modify spontaneous
[Ca2]i oscillations and to prevent the [Ca2]i low-
ering e¡ect of vinpocetine. Interestingly, the physio-
logical relevance of type I PDE-cGMP-PKG path-
way in the occurrence of [Ca2]i oscillation in GH3
cells was further demonstrated by the evidence that
the blockade of extracellular Ca2 entrance de-
creased intracellular steady-state levels of cGMP.
This role seems to be selective for the type I PDE-
cGMP-PKG pathway since cAMP levels were not
a¡ected by the blockade of Ca2 entrance into the
cells.
In order to explain the present results, several
mechanisms can be taken into consideration. PKG
could indeed interfere with the components of both
the plasmamembrane oscillator, like L-type VSCC
and Ca2-ATPases, as well as the endoplasmic retic-
ulum oscillator, like sarcoplasmic Ca2-ATPases and
ionic channels. In particular, it has been demon-
strated that in mammalian cardiac myocytes, L-
type Ca2 currents are markedly inhibited by PKG
activation obtained either through exogenous admin-
istration of cGMP or through cGMP elevation in-
duced by the unspeci¢c blocker of PDE isomethyl-
butylxanthine (IBMX) [25,26]. In addition, evidence
has been provided showing that PKG can reduce
[Ca2]i by activating Ca2 extrusion mechanisms, in-
cluding the plasmamembrane-associated calmodulin-
stimulated Ca2-ATPase [27^29] and the Na/Ca2
exchanger [30]. Furthermore, the possibility exists
that PKG activation can promote Ca2 removal
from the cytosol into the intracellular stores by stim-
ulating sarcoplasmic Ca2-ATPase [31,32], and/or re-
duce Ca2 ions mobilization from the IP3-sensitive
Ca2 stores by inhibiting IP3 production [33].
The results obtained from the present study sug-
gest that the occurrence of [Ca2]i oscillations in
GH3 cells may be regulated by the activity of type
I PDE-cGMP-PKG pathway which seems to be con-
trolled by [Ca2]i.
In fact, when the Ca2 entrance is blocked, this
pathway is inhibited, whereas, when the bivalent cat-
ion entrance is not prevented, this biochemical path-
way might exert its inhibitory action on L-type
VSCC.
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